Xylem Deferred Long Term Liab from 2010 to 2024

XYL Stock  USD 128.94  2.07  1.63%   
Xylem Deferred Long Term Liabilities yearly trend continues to be quite stable with very little volatility. The value of Deferred Long Term Liabilities is projected to decrease to about 254.2 M. Deferred Long Term Liabilities is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. View All Fundamentals
 
Deferred Long Term Liabilities  
First Reported
2011-09-30
Previous Quarter
215 M
Current Value
738 M
Quarterly Volatility
104 M
 
Yuan Drop
 
Covid
Check Xylem financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Xylem's main balance sheet or income statement drivers, such as Depreciation And Amortization of 457.8 M, Interest Expense of 57.9 M or Selling General Administrative of 1.2 B, as well as many indicators such as Price To Sales Ratio of 1.9, Dividend Yield of 0.0129 or PTB Ratio of 3.08. Xylem financial statements analysis is a perfect complement when working with Xylem Valuation or Volatility modules.
  
Check out the analysis of Xylem Correlation against competitors.

Latest Xylem's Deferred Long Term Liab Growth Pattern

Below is the plot of the Deferred Long Term Liab of Xylem Inc over the last few years. It is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. Xylem's Deferred Long Term Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Xylem's overall financial position and show how it may be relating to other accounts over time.
Deferred Long Term Liab10 Years Trend
Slightly volatile
   Deferred Long Term Liab   
       Timeline  

Xylem Deferred Long Term Liab Regression Statistics

Arithmetic Mean229,832,778
Geometric Mean220,312,813
Coefficient Of Variation29.12
Mean Deviation55,577,259
Median242,000,000
Standard Deviation66,936,488
Sample Variance4480.5T
Range234M
R-Value0.57
Mean Square Error3266.2T
R-Squared0.32
Significance0.03
Slope8,507,649
Total Sum of Squares62726.9T

Xylem Deferred Long Term Liab History

2024254.2 M
2023255.3 M
2022222 M
2021287 M
2020242 M
2019310 M
2018303 M

About Xylem Financial Statements

Xylem investors utilize fundamental indicators, such as Deferred Long Term Liab, to predict how Xylem Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Deferred Long Term Liabilities255.3 M254.2 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Xylem Inc is a strong investment it is important to analyze Xylem's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Xylem's future performance. For an informed investment choice regarding Xylem Stock, refer to the following important reports:
Check out the analysis of Xylem Correlation against competitors.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Industrial Machinery & Supplies & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xylem. If investors know Xylem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xylem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.413
Dividend Share
1.41
Earnings Share
3.48
Revenue Per Share
34.788
Quarterly Revenue Growth
0.013
The market value of Xylem Inc is measured differently than its book value, which is the value of Xylem that is recorded on the company's balance sheet. Investors also form their own opinion of Xylem's value that differs from its market value or its book value, called intrinsic value, which is Xylem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xylem's market value can be influenced by many factors that don't directly affect Xylem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xylem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Xylem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xylem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.